Results per Page:
Inside scorpion venom: A future Rx for arthritis?
Tiny scorpion-derived proteins deliver arthritis drugs to joints in rat study
Unlocking a new path for cystine-dense peptides
From the Olson Lab, Clinical Research Division and the Strong Lab, Basic Sciences and Vaccine and Infectious Disease Divisions
Good News: CBS 'Sunday Morning' to feature Dr. Jim Olson's Tumor Paint research this weekend
Celebrating faculty and staff achievements
New methods to design small, targeted proteins with shapes not found in nature
Researchers develop methods to design small, targeted proteins with shapes not found in nature
Mom of Seahawks' Justin Britt teams up with grieving dad to learn about new research
The mother of Seahawks' Justin Britt teamed up with a grieving father to learn about promising new research that could help others
‘A crack in the door’: Glimpses of hope for the future of brain cancer care
Fred Hutch researchers discuss brain tumor treatments in the works — and what’s coming next
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
Mielcarek study may change the practice of blood stem-cell transplantation
Celebrating faculty and staff achievements
‘Turn it into something good’
Fred Hutch intern Margo Coxon shares the root of her desire to find a cure
After three years of rehabilitation, 17-year-old brain tumor survivor gets his wish to walk through the doors of Fred Hutch
After three years of rehabilitation, 17-year-old brain tumor survivor gets his wish to walk through the doors of Fred Hutch
Tumor Paint approved for first U.S. trial
Molecule that highlights cancer cells for surgery was pioneered by Fred Hutch’s Dr. Jim Olson, licensed by Blaze Bioscience Inc.
‘Tumor Paint’ research of pediatric oncologist Jim Olson featured in short film -- a Sundance Festival finalist
Three-minute documentary about Seattle researcher’s discovery is online for viewing and voting